Annovis Bio CFO resigns; CEO Maccecchini appointed acting CFO

Annovis Bio, Inc.

Andrew Walsh resigned as VP of Finance and Principal Financial Officer, effective Aug 22, 2025.
Resignation was not due to any disagreement with the company's operations, policies, or practices.
CEO Maria Maccecchini appointed Acting CFO effective Aug 15, 2025, by unanimous board vote.
Company has begun actively searching for a permanent Chief Financial Officer.

item 5.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.